This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Hains DS, Kelleher K, Wei C, Smoyer W.Demographic and cost analysis of pediatric nephrotic syndrome hospitalizations utilizing the 2000 KID Inpatient Database. 2009 Annual Meeting of the Pediatric Academic Societies: abstr. 2834.299, 2 May 2009. Available from: URL: http://www.pas-meeting.org
Wei C, Wang W, Hains D, Smoyer WE, Benndorf R.National costs and complications for pediatric nephrotic syndrome: analysis of the KIDS Inpatient Database. 2009 Annual Meeting of the Pediatric Academic Societies: abstr. 2834.300, 2 May 2009. Available from: URL: http://www.pas-meeting.org
Freedman S, Steiner M, Chan K.Ondansetron administration in emergency departments to children with gastroenteritis: a cost-benefit and cost-effectiveness analysis. 2009 Annual Meeting of the Pediatric Academic Societies: abstr. 3210.5, 3 May 2009. Available from: URL: http://www.pas-meeting.org
Dukhovny D, Lorch SA, Schmidt B, Doyle LW, Kok JH, Roberts RS, Kamholz K, Wang N, Zupancic JAF, Caffeine for Apnea of Prematurity Trial Group.Economic evaluation alongside the Caffeine for Apnea of Prematurity (CAP) trial: short term outcomes. 2009 Annual Meeting of the Pediatric Academic Societies: abstr. 2841.382, 2 May 2009. Available from: URL: http://www.pas-meeting.org
Hudson O, Hoekstra F, Gerkin R, Dajani T.A cost effectiveness analysis of growth hormone therapy: when to stop treatment. 2009 Annual Meeting of the Pediatric Academic Societies: abstr. 2826.243, 2 May 2009. Available from: URL: http://www.pas-meeting.org
Rights and permissions
About this article
Cite this article
News from the 2009 Pediatric Academic Societies Annual Meeting. Pharmacoecon. Outcomes News 578, 3–4 (2009). https://doi.org/10.2165/00151234-200905780-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905780-00005